Immunotherapy News and Research

Latest Immunotherapy News and Research

Computational method could predict immunotherapy response in patients with advanced melanoma

A computational method that combines clinicodemographic variables with deep learning of pre-treatment histology images could predict response to immune checkpoint blockade among patients with advanced melanoma.

18 Nov 2020

New study may shed light on the adaptive immune response to COVID-19

New research funded by the National Cancer Institute (NCI) aims to boost understanding of how the immune system responds to COVID-19, from the start of infection to recovery.

18 Nov 2020

Widespread COVID-19 testing may be possible with new dried blood tests

Researchers have developed dried blood spot sample testing that could be instrumental in preventing the spread of SARS- CoV-2.

17 Nov 2020

Lower dairy intake may be beneficial for people with metabolic syndrome

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggests lower dairy intake may be beneficial for people with metabolic syndrome.

17 Nov 2020

Study shows food allergies have huge emotional impact on Asian families

Studies have shown that food allergies negatively affect the quality of life of those who suffer with them. A new study being presented at this year's virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting.

17 Nov 2020

Masks can cause more problems in people with skin allergies

Throughout the course of the COVID-19 pandemic, those able to wear a face mask have been encouraged to do so to prevent transmission of the virus. For some people with skin allergies, wearing a mask can cause further problems.

17 Nov 2020

COVID-19 pandemic drives asthma patients to use telemedicine

COVID-19 has, among other things, pushed patients of all ages into greater use of telemedicine to carry out regular doctor visits.

16 Nov 2020

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

The first randomized phase 3 clinical trial ever to be conducted in patients with advanced cancer of the anal canal is now open and enrolling patients.

16 Nov 2020

New antibody fragment helps reduce Aβ levels in old mice with Alzheimer’s disease

Alzheimer's disease is the most common dementia worldwide and it is characterized by learning impairment, memory loss, disorientation, and anxiety, among other behavioral and psychological symptoms.

16 Nov 2020

New tool predicts which cancer patients will respond positively to immunotherapy

An international group led by Dr Banafshe Larijani, an Ikerbasque researcher seconded to the Biofisika Institute (UPV/EHU-University of the Basque Country, CSIC), has developed a new diagnostic method making it possible to accurately predict which cancer patients will respond positively to immunotherapy.

16 Nov 2020

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's Division of Cancer Diagnosis and Treatment, part of the National Institutes of Health, have shown that the immunotherapy combination of ipilimumab and nivolumab shrinks rare angiosarcoma tumors in 25 percent of all patients, with some having an even stronger response to the drug combination.

15 Nov 2020

Promising SARS-CoV-2 N epitope for more accurate diagnostic and surveillance antibody testing

A new study published on the preprint server bioRxiv in November 2020 describes the virus's N protein as a promising epitope for serology.

12 Nov 2020

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting & Pre-Conference Programs.

11 Nov 2020

A promising vaccine for treating poorly immunogenic tumors

Patients with cancer have multiple treatment options available to them today, but each has its drawbacks. Chemotherapy kills rapidly dividing cancer cells, but it also damages healthy cells in the body and often does not effectively prevent tumor metastasis or disease recurrence.

11 Nov 2020

Clinical study of personalized cancer vaccine to expand after promising preliminary data

A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.

10 Nov 2020

Immunotherapy drugs trigger inflammatory arthritis in subset of cancer patients

Since doctors began treating cancer patients with immunotherapy drugs called checkpoint inhibitors nearly a decade ago, they have observed that a subset of these patients experience a side effect that clinically looks like inflammatory arthritis.

10 Nov 2020

White blood cells can be used to attack tumors after completing a special training

Scientists at the National Center for Tumor Diseases Dresden and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program - be utilized for the treatment of tumors.

6 Nov 2020

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Pancreatic cancer is highly lethal: according to the National Cancer Institute, only about 10 percent of patients remain alive five years after diagnosis.

6 Nov 2020

Early administration of combination therapy can be effective for treating stomach cancer

Immunotherapy for stomach cancer may work better if the therapy is delivered earlier in the course of disease and in combination with standard chemotherapy, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons suggests.

5 Nov 2020

Repurposing an anxiety drug to increase the efficacy of therapies for metastatic melanoma

There are times when adding something new to the mix makes it better. Give Popeye some spinach, and you've got a fighting machine. Give Mario a mushroom, and he becomes invincible. Without drinking a potion, Alice in Wonderland would never fit through the door.

5 Nov 2020

Immunotherapy News and Research

Latest Immunotherapy News and Research

Computational method could predict immunotherapy response in patients with advanced melanoma

New study may shed light on the adaptive immune response to COVID-19

Widespread COVID-19 testing may be possible with new dried blood tests

Lower dairy intake may be beneficial for people with metabolic syndrome

Study shows food allergies have huge emotional impact on Asian families

Masks can cause more problems in people with skin allergies

COVID-19 pandemic drives asthma patients to use telemedicine

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

New antibody fragment helps reduce Aβ levels in old mice with Alzheimer’s disease

New tool predicts which cancer patients will respond positively to immunotherapy

Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients

Promising SARS-CoV-2 N epitope for more accurate diagnostic and surveillance antibody testing

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

A promising vaccine for treating poorly immunogenic tumors

Clinical study of personalized cancer vaccine to expand after promising preliminary data

Immunotherapy drugs trigger inflammatory arthritis in subset of cancer patients

White blood cells can be used to attack tumors after completing a special training

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Early administration of combination therapy can be effective for treating stomach cancer

Repurposing an anxiety drug to increase the efficacy of therapies for metastatic melanoma

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in